BioSpace News Archive

Business

Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair

Kane Biotech Inc. Dr. Robert Huizinga was elected as a director of the Company.

February 22, 2024

·

4 min read

BioForest

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

Nautilus Biotechnology, Inc. today announced the company will be participating in the TD Cowen 44th Annual Healthcare Conference.

February 22, 2024

·

1 min read

Genetown

Centessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference

Centessa Pharmaceuticals plc today announced that members of its management team will participate in TD Cowen’s 44th Annual Health Care Conference in Boston, MA.

February 22, 2024

·

1 min read

Biotech Beach

American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis

Bionano Genomics, Inc., announced that optical genome mapping was included for the first time in the American College of Medical Genetics and Genomics technical laboratory standards documentation for solid tumor analysis.

February 22, 2024

·

6 min read

Business

Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences

Ansa Biotechnologies, Inc. , a pioneer of next-generation DNA synthesis, today announced the appointment of Jason T. Gammack as its new chief executive officer.

February 22, 2024

·

3 min read

Biotech Bay

Twist Bioscience to Present at Upcoming Investor Conferences - February 22, 2024

Twist Bioscience Corporation today announced that its executives will participate in fireside chats at the following upcoming investor conferences.

February 22, 2024

·

2 min read

Drug Development

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium

Kineta, Inc. announced today that it will present new preclinical data on KVA12123, the Company’s anti-VISTA antibody, in acute myeloid leukemia (AML) at the American Association for Cancer Research (AACR) Blood Cancer Discovery Symposium, to be held on March 4-6 in Boston, Massachusetts.

February 22, 2024

·

2 min read

Drug Development

Ashvattha Therapeutics Announces First Patient Enrolled in Expanded Phase 1/2 Study of Imaging Agent 18F-OP-801 in Additional Neurological Indications

Ashvattha Therapeutics today announced that the first patient has been enrolled in its expanded Phase 1/2 study of 18F-OP-801, a hydroxyl dendrimer (HD) imaging agent.

February 22, 2024

·

3 min read

Biotech Bay

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot study for the Company’s Next Generation Remote Patient Monitoring (RPM) device for Obstructive Sleep Apnea (OSA).

February 22, 2024

·

7 min read

Drug Development

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

Avenue Therapeutics, Inc. today announced the publication of preclinical in vivo data in Drug Development Research highlighting BAER-101’s full suppression of seizure activity using the Genetic Absence Epilepsy Rats from Strasbourg (“GAERS”) model of absence epilepsy.

February 22, 2024

·

6 min read